Download
13063_2024_Article_8114.pdf 1016,60KB
WeightNameValue
1000 Titel
  • Tolerance induction through early feeding to prevent food allergy in infants and children with sensitization against food allergens (TIFFANI): rationale, study design, and methods of a randomized controlled trial
1000 Autor/in
  1. Kalb, Birgit |
  2. Meixner, Lara |
  3. Heller, Stephanie |
  4. Dölle-Bierke, Sabine |
  5. Roll, Stephanie |
  6. Tissen-Diabaté, Tatjana |
  7. Lau, Susanne |
  8. Forslund, Sofia |
  9. Marenholz, Ingo |
  10. Lee, Young-Ae |
  11. Thiel, Andreas |
  12. Babina, Magda |
  13. Scheffel, Jörg |
  14. Worm, Margitta |
  15. Beyer, Kirsten |
1000 Verlag BioMed Central
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-04-19
1000 Erschienen in
1000 Quellenangabe
  • 25(1):272
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13063-024-08114-9 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11031852/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>Children with sensitization against foods have to be orally food-challenged before eating these foods for the first time. However, the waiting time for an oral food challenge (OFC) in Germany is about 3–6 months. In contrast, there are hints that an early introduction of allergenic foods might be protective regarding the development of food allergy. The aim of this clinical trial is therefore to investigate, whether an introduction and regular consumption of small amounts of food allergens is safe and will result in an increase of tolerance in children with sensitization against food allergens with unknown clinical relevance.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>In this randomized, placebo-controlled, double-blind, single-center trial, 138 children (8 months to 4 years of age) sensitized to the target allergen(s) hen’s egg, cow’s milk, peanuts, and/or hazelnuts with unknown clinical relevance will be randomized in a 1:1 ratio to either an active or a placebo group, daily receiving a rusk-like biscuit powder with or without the target allergen(s) for 3–6 months until an OFC will be performed in routine diagnostics. The primary endpoint is an IgE-mediated food allergy to the primary target allergen, after the interventional period.</jats:p> </jats:sec><jats:sec> <jats:title>Discussion</jats:title> <jats:p>Children with sensitization against food allergens with unknown clinical relevance often have to avoid the corresponding foods for several months until an OFC is performed. Therefore, the “window of opportunity” for an early preventive introduction of allergenic foods might be missed. This trial will assess whether an introduction of small allergen amounts will favor tolerance development in these children.</jats:p> </jats:sec><jats:sec> <jats:title>Trial registration</jats:title> <jats:p>German Clinical Trials Register DRKS00032769. Registered on 02 October 2023.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Female [MeSH]
lokal Window of opportunity
lokal Chickens [MeSH]
lokal Study Protocol
lokal Humans [MeSH]
lokal Eczema
lokal Prevention
lokal Sensitization
lokal Animals [MeSH]
lokal Food Hypersensitivity/diagnosis [MeSH]
lokal Food Hypersensitivity/prevention
lokal Food allergy
lokal Infant [MeSH]
lokal Milk/adverse effects [MeSH]
lokal Immune Tolerance [MeSH]
lokal Cattle [MeSH]
lokal Allergens/adverse effects [MeSH]
lokal Early allergen introduction
lokal Child [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-3104-6736|https://frl.publisso.de/adhoc/uri/TWVpeG5lciwgTGFyYQ==|https://frl.publisso.de/adhoc/uri/SGVsbGVyLCBTdGVwaGFuaWU=|https://frl.publisso.de/adhoc/uri/RMO2bGxlLUJpZXJrZSwgU2FiaW5l|https://frl.publisso.de/adhoc/uri/Um9sbCwgU3RlcGhhbmll|https://frl.publisso.de/adhoc/uri/VGlzc2VuLURpYWJhdMOpLCBUYXRqYW5h|https://frl.publisso.de/adhoc/uri/TGF1LCBTdXNhbm5l|https://frl.publisso.de/adhoc/uri/Rm9yc2x1bmQsIFNvZmlh|https://frl.publisso.de/adhoc/uri/TWFyZW5ob2x6LCBJbmdv|https://frl.publisso.de/adhoc/uri/TGVlLCBZb3VuZy1BZQ==|https://frl.publisso.de/adhoc/uri/VGhpZWwsIEFuZHJlYXM=|https://frl.publisso.de/adhoc/uri/QmFiaW5hLCBNYWdkYQ==|https://frl.publisso.de/adhoc/uri/U2NoZWZmZWwsIErDtnJn|https://frl.publisso.de/adhoc/uri/V29ybSwgTWFyZ2l0dGE=|https://frl.publisso.de/adhoc/uri/QmV5ZXIsIEtpcnN0ZW4=
1000 Hinweis
  • DeepGreen-ID: 7a42a6511f864bf3b1cda3be8f7cb056 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Deutsche Forschungsgemeinschaft |
  2. Charité – Universitätsmedizin Berlin |
1000 Fördernummer
  1. -
  2. -
1000 Förderprogramm
  1. -
  2. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Deutsche Forschungsgemeinschaft |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer Charité – Universitätsmedizin Berlin |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6518675.rdf
1000 Erstellt am 2025-07-05T12:53:52.846+0200
1000 Erstellt von 322
1000 beschreibt frl:6518675
1000 Zuletzt bearbeitet 2025-08-15T20:46:27.710+0200
1000 Objekt bearb. Fri Aug 15 20:46:27 CEST 2025
1000 Vgl. frl:6518675
1000 Oai Id
  1. oai:frl.publisso.de:frl:6518675 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source